Compare PKE & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PKE | CBLL |
|---|---|---|
| Founded | 1954 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Military/Government/Technical | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 796.7M | 750.1M |
| IPO Year | 1994 | N/A |
| Metric | PKE | CBLL |
|---|---|---|
| Price | $36.92 | $19.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $23.20 |
| AVG Volume (30 Days) | ★ 418.0K | 383.2K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 93.10 | N/A |
| EPS | ★ 0.56 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | N/A | $28.44 |
| P/E Ratio | $67.36 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.23 | $10.85 |
| 52 Week High | $39.86 | $24.33 |
| Indicator | PKE | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 58.87 | 58.69 |
| Support Level | $31.16 | $18.91 |
| Resistance Level | $38.20 | $21.32 |
| Average True Range (ATR) | 1.97 | 0.85 |
| MACD | 0.47 | 0.16 |
| Stochastic Oscillator | 68.33 | 76.15 |
Park Aerospace Corp is an aerospace company that develops and manufactures composite materials used to produce composite structures for the aerospace market. Its products include film adhesives, lightning strike protection materials, specialty ablative materials for rocket motors and nozzles, and materials for radome applications. The Company offers composite materials designed for hand lay-up and automated fiber placement (AFP) manufacturing applications, which are used in jet engines, large and regional transport aircraft, military aircraft, unmanned aerial vehicles (UAVs), business jets, general aviation aircraft, and rotary wing aircraft. It operates in North America, Asia, and Europe, with North America generating maximum revenue.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.